These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19956435)

  • 1. Nuclear EGFR is required for cisplatin resistance and DNA repair.
    Hsu SC; Miller SA; Wang Y; Hung MC
    Am J Transl Res; 2009 Mar; 1(3):249-58. PubMed ID: 19956435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.
    Liccardi G; Hartley JA; Hochhauser D
    Cancer Res; 2011 Feb; 71(3):1103-14. PubMed ID: 21266349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.
    Subramanian PD; An Z; Yu JR; Park WY
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):753-62. PubMed ID: 27535835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654.
    Dittmann K; Mayer C; Fehrenbacher B; Schaller M; Kehlbach R; Rodemann HP
    FEBS Lett; 2010 Sep; 584(18):3878-84. PubMed ID: 20692258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair.
    Teng K; Zhang Y; Hu X; Ding Y; Gong R; Liu L
    Onco Targets Ther; 2015; 8():809-18. PubMed ID: 25926742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel tripartite nuclear localization sequence in the EGFR family.
    Hsu SC; Hung MC
    J Biol Chem; 2007 Apr; 282(14):10432-40. PubMed ID: 17283074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation.
    Wanner G; Mayer C; Kehlbach R; Rodemann HP; Dittmann K
    Radiother Oncol; 2008 Mar; 86(3):383-90. PubMed ID: 18037521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
    Raju U; Riesterer O; Wang ZQ; Molkentine DP; Molkentine JM; Johnson FM; Glisson B; Milas L; Ang KK
    Radiother Oncol; 2012 Nov; 105(2):241-9. PubMed ID: 23010482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access.
    Dittmann K; Mayer C; Fehrenbacher B; Schaller M; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):317-22. PubMed ID: 21704408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of EGFR nuclear shuttling decreases irradiation resistance in HeLa cells.
    Wei H; Zhu Z; Lu L
    Folia Histochem Cytobiol; 2017; 55(2):43-51. PubMed ID: 28518211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase.
    Dittmann K; Mayer C; Fehrenbacher B; Schaller M; Raju U; Milas L; Chen DJ; Kehlbach R; Rodemann HP
    J Biol Chem; 2005 Sep; 280(35):31182-9. PubMed ID: 16000298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma.
    Das AK; Chen BP; Story MD; Sato M; Minna JD; Chen DJ; Nirodi CS
    Cancer Res; 2007 Jun; 67(11):5267-74. PubMed ID: 17545606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function.
    Dittmann K; Mayer C; Rodemann HP
    Strahlenther Onkol; 2010 Jan; 186(1):1-6. PubMed ID: 20082181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.
    Dittmann K; Mayer C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2008 Mar; 86(3):375-82. PubMed ID: 18237807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents.
    Lin MZ; Marzec KA; Martin JL; Baxter RC
    Oncogene; 2014 Jan; 33(1):85-96. PubMed ID: 23178489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK.
    Dittmann K; Mayer C; Kehlbach R; Rodemann HP
    Mol Cancer; 2008 Sep; 7():69. PubMed ID: 18789131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CRM1-dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization.
    Brieger A; Adam R; Passmann S; Plotz G; Zeuzem S; Trojan J
    Genes Chromosomes Cancer; 2011 Feb; 50(2):59-70. PubMed ID: 21064154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839).
    Friedmann B; Caplin M; Hartley JA; Hochhauser D
    Clin Cancer Res; 2004 Oct; 10(19):6476-86. PubMed ID: 15475435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
    Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
    Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of p21CDKN1A after DNA damage is independent of type of lesion, and is not required for DNA repair.
    Savio M; Coppa T; Cazzalini O; Perucca P; Necchi D; Nardo T; Stivala LA; Prosperi E
    DNA Repair (Amst); 2009 Jul; 8(7):778-85. PubMed ID: 19321391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.